Biochanin A - A G6PD inhibitor: In silico and in vitro studies in non-small cell lung cancer cells (A549)

In conclusion, our findings highlight the potential of BA as a therapeutic agent in cancer treatment, specifically by targeting G6PD and related pathways. BA's varied effects, which range from anti-inflammatory capabilities to metastasis reduction, make it an appealing option for future investigation in the development of new cancer therapeutics.PMID:38266663 | DOI:10.1016/j.tiv.2024.105785

Source: Toxicology in Vitro - January 24, 2024 Category: Toxicology Authors: Anjali B Thakkar Ramalingam B Subramanian Sampark S Thakkar Vasudev R Thakkar Parth Thakor Source Type: research